BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) announced the pricing on October 8, 2013 of a total offering of $680 million of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE